Intra-Cellular Therapies IncEigentümerstruktur
| Preis (2025-04-01) | 52W Hoch | 52W Tief |
| 131.87 USD | 0 USD | 0 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 103,5 USD | 9 | 5 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 106.522.000 | 2,54 | 1,2 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Intra-Cellular Therapies Inc
Mitarbeiter 860
Handelsplatz NASDAQ
Ticker Symbol ITCI
IPO Datum 2014-01-07
Adresse 135 Route 202/206, Bedminster, NJ, United States, 07921
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Sharon Mates Ph.D. | Co-Founder, Chairman & CEO |
| 2 | Mr. Michael I. Halstead J.D. | President |
| 3 | Mr. Sanjeev Narula | Executive VP, CFO & Treasurer |
| 4 | Dr. Suresh K. Durgam M.D. | Executive VP & Chief Medical Officer |
| 5 | Mr. Mark Neumann | EVP & Chief Commercial Officer |
| 6 | Dr. Robert E. Davis Ph.D. | Senior VP & Chief Scientific Officer |
| 7 | Mr. Juan Fernando Sanchez M.D. | Vice President of Corporate Communications & Investor Relations |
| 8 | Ms. Karen Patruno Sheehy Esq. | Senior VP & Chief Compliance Officer |
| 9 | John P. Condon | Senior VP, General Counsel & Secretary |
| 10 | Dr. Michael Olchaskey Pharm.D. | Senior VP & Head of Regulatory Affairs |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Pentwater Capital Management LP | 0,00% | 0,00 Mio. USD |
| 4 | Davidson Kempner Capital Management LP | 0,00% | 0,00 Mio. USD |
| 5 | NORGES BANK | 0,00% | 0,00 Mio. USD |
| 6 | UBS O'Connor LLC | 0,00% | 0,00 Mio. USD |
| 7 | Amvescap Plc. | 0,00% | 0,00 Mio. USD |
| 8 | Farallon Capital Management, L.L.C. | 0,00% | 0,00 Mio. USD |
| 9 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 10 | Balyasny Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 11 | Deep Track Capital, LP | 0,00% | 0,00 Mio. USD |
| 12 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 14 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 15 | Weiss Asset Management LP | 0,00% | 0,00 Mio. USD |
| 16 | Glazer Capital, LLC | 0,00% | 0,00 Mio. USD |
| 17 | Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 18 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 19 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0,00% | 0,00 Mio. USD |
| 20 | Test Hedge Fund Mgmt | 0,00% | 0,00 Mio. USD |